Skip to content

Cannabis for anxiety: all studies

Page 6 of 7: studies 51 to 60 of 61, newest first. Back to the cannabis for anxiety overview

Research

Psychedelic symptoms of cannabis and cocaine use as a function of trait impulsivity

Journal of Psychopharmacology January 8, 2015 JHP van Wel, DB Spronk, Kim P. C. Kuypers et al. 23 citations

Trait impulsivity has been linked to addiction in humans. It has been suggested that drug users with high trait impulsivity levels are more sensitive to subjective drug intoxication. This study assessed whether subjective response to drugs differs between drug users with normal or high levels of trait impulsivity. Regular drug users (N = 122) received doses of cocaine HCl, cannabis, and placebo...

“Noids” in a nutshell: everything you (don’t) want to know about synthetic cannabimimetics

Advances in Dual Diagnosis August 12, 2014 Duccio Papanti, Laura Orsolini, Giulia Francesconi et al. 24 citations

Purpose – “Spice” products are synthetic cannabimimetics (SC; also called “synthetic cannabinoids”)-based designer drugs used as a legal alternative to cannabis for their very strong tetrahydrocannabinol (THC)-like effects. The purpose of this paper is to provide an analysis of more recent clinical and pharmacology/toxicology findings relating to SC and describe how they could impact on health,...

DOI: 10.1108/add-02-2014-0006 (opens in new tab) Cannabis Anxiety Synthetic cannabinoids Cannabinoid receptor +3

Mitigation of post‐traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence

Drug Testing and Analysis June 26, 2012 Torsten Passie, Hinderk M. Emrich, Matthias Karst et al. 114 citations

It is known from clinical studies that some patients attempt to cope with the symptoms of post-traumatic stress disorder (PTSD) by using recreational drugs. This review presents a case report of a 19-year-old male patient with a spectrum of severe PTSD symptoms, such as intense flashbacks, panic attacks, and self-mutilation, who discovered that some of his major symptoms were dramatically...

Modulation of effective connectivity during emotional processing by Δ9-tetrahydrocannabinol and cannabidiol

The International Journal of Neuropsychopharmacology September 24, 2009 Paolo Fusar‐poli, Paul Allen, Sagnik Bhattacharyya et al. 165 citations

Cannabis sativa, the most widely used illicit drug, has profound effects on levels of anxiety in animals and humans. Although recent studies have helped provide a better understanding of the neurofunctional correlates of these effects, indicating the involvement of the amygdala and cingulate cortex, their reciprocal influence is still mostly unknown. In this study dynamic causal modelling (DCM)...

Modulation of Mediotemporal and Ventrostriatal Function in Humans by Δ9-Tetrahydrocannabinol

Archives of General Psychiatry April 1, 2009 Sagnik Bhattacharyya, Paolo Fusar‐poli, Stefan Borgwardt et al. 250 citations

CONTEXT: Cannabis sativa use can impair verbal learning, provoke acute psychosis, and increase the risk of schizophrenia. It is unclear where C. sativa acts in the human brain to modulate verbal learning and to induce psychotic symptoms. OBJECTIVES: To investigate the effects of 2 main psychoactive constituents of C. sativa, Delta9-tetrahydrocannabinol (Delta9-THC) and cannabidiol, on regional...

Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing

Archives of General Psychiatry 2009 Paolo Fusar‐poli, José A. Crippa, Sagnik Bhattacharyya et al. 461 citations

CONTEXT: Cannabis use can both increase and reduce anxiety in humans. The neurophysiological substrates of these effects are unknown. OBJECTIVE: To investigate the effects of 2 main psychoactive constituents of Cannabis sativa (Delta9-tetrahydrocannabinol [Delta9-THC] and cannabidiol [CBD]) on regional brain function during emotional processing. DESIGN: Subjects were studied on 3 separate...

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug

Brazilian Journal of Medical and Biological Research April 1, 2006 Antônio Waldo Zuardi, José A. Crippa, Jaime E. C. Hallak et al. 411 citations

A high dose of delta9-tetrahydrocannabinol, the main Cannabis sativa (cannabis) component, induces anxiety and psychotic-like symptoms in healthy volunteers. These effects of delta9-tetrahydrocannabinol are significantly reduced by cannabidiol (CBD), a cannabis constituent which is devoid of the typical effects of the plant. This observation led us to suspect that CBD could have anxiolytic...

Patterns, Trends, and Meanings of Drug Use by Dance-drug Users in Edinburgh, Scotland

Drugs Education Prevention and Policy June 1, 2004 Sarah Riley, Emma Hayward 52 citations

A survey of drug use in the past year was completed by 124 clubbers (50% male, 50% female, age range 14–44, mean 24 years). Participants were self selecting and recruited in clubs and pre-club bars. Prevalence rates for alcohol, cannabis, and ecstasy were over 80%; 63% reported cocaine and 53% amphetamine use, 15%–43% used ketamine, psilocybin, LSD and nitrites. A pattern of polydrug and...

Cannabis‐induced Koro in Americans

Addiction November 1, 2001 Mitch Earleywine 57 citations

AIMS: Koro, an acute panic reaction related to the perception of penile retraction, was once considered limited to specific cultures. The disorder has appeared as part of a panic response to cannabis, but only in citizens of India. This study looked for cannabis-induced Koro in Americans. DESIGN: Given the relative rarity of cannabis-induced Koro, this work focused on individual case studies....

Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms

Journal of Psychopharmacology May 1, 2001 Nicholas Macinnes, Sheila L. Handley, G. F. A. Harding 120 citations

Previous work has indicated recreational use of methylenedioxymethamphetamine (MDMA or ecstasy) is associated with elevated scores on self-report measures of depression. We sought to examine the long-term effects of consumption on depression in a group of individuals who had consumed large quantities of the drug in the past, but were now leading relatively drug free lives. Respondents to this...